Latest filing published 03 Jul 2014 for Rennova Health, Inc., €4,323.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -66.6%Entry US$4,477,948.00 · Close at T+365 US$1,493,699.38
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
James Karis: trading record in brief
James Karis appears in our data through filings on Rennova Health, Inc. shares, published by SEC (Form 4). The record holds 2 filings, for trades running from 12 July 2012 to 23 June 2014.
No open-market sale appears; the market trades are 1 purchase worth €4,323. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant. Since January 2014: 1 purchase and no sales on the market.
Most recently, on 3 July 2014, the filings show an open-market purchase worth €4,323 in Rennova Health, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to James Karis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,000 shares@ US$1.96Common Stock, 0.01 par valueSEC:0001140361-14-027773:0Canonical exit: 21 Sept 2014 (T+90)
- 239,417 shares0Common StockSEC:0001470112-12-000002:0
2 of 2 declarations